Reactive oxygen species (ROS)-response nanomedicine through knocking down a novel therapeutic target NEDD8-conjugating enzyme UBC12 (UBE2M) in the treatment of liver cancer
- Resource Type
- Article
- Source
- In
Materials & Design June 2021 204 - Subject
- Language
- ISSN
- 0264-1275